Display options
Share it on

PeerJ. 2017 Mar 16;5:e3105. doi: 10.7717/peerj.3105. eCollection 2017.

Evaluation of procedures for typing of group B .

PeerJ

Hans-Christian Slotved, Steen Hoffmann

Affiliations

  1. Neisseria and Streptococcus Reference Laboratory, Department of Microbiology and Infection Control, Statens Serum Institut , Copenhagen , Denmark.

PMID: 28321367 PMCID: PMC5357338 DOI: 10.7717/peerj.3105

Abstract

BACKGROUND: This study evaluates two procedures for typing of

METHODS: A total of 616 clinical GBS isolates from 2010 to 2014 were tested with both a latex test and the LP test. Among these, 66 isolates were genotyped by PCR, including 41 isolates that were phenotypically NT.

RESULTS: The latex test provided a serotype for 83.8% of the isolates (95% CI [80.7-86.6]) compared to 87.5% (95% CI [84.6-90.0]) obtained by the LP method. The two assays provided identical capsular identification for all sero-typeable isolates (excluding NT isolates). The PCR assay provided a genotype designation to the 41 isolates defined as phenotypically NT isolates.

DISCUSSION: We found that the latex test showed a slightly lower identification percentage than the LP test. Our recommendation is to use the latex agglutination as the routine primary assay for GBS surveillance, and then use the more labour intensive precipitation test on the NT isolates to increase the serotyping rate. A genotype could be assigned to all the phenotypically NT isolates, however, as a consequence genotyping will overestimate the coverage from possible future capsular polysaccharide based GBS vaccines.

Keywords: Group B Streptococcus; Lancefield precipitation; Latex test; Serotyping

Conflict of interest statement

The authors declare there are no competing interests.

References

  1. Trop Med Int Health. 2015 Nov;20(11):1516-1524 - PubMed
  2. Vaccine. 2013 Aug 28;31 Suppl 4:D7-12 - PubMed
  3. J Microbiol Methods. 2010 Feb;80(2):212-4 - PubMed
  4. J Microbiol Methods. 2015 Jan;108:31-5 - PubMed
  5. Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1071-7 - PubMed
  6. BMC Pediatr. 2016 Jul 07;16:82 - PubMed
  7. Vaccine. 2016 Jun 3;34(26):2876-9 - PubMed
  8. Vaccine. 2013 Aug 28;31 Suppl 4:D20-6 - PubMed
  9. J Clin Microbiol. 2007 Sep;45(9):2929-36 - PubMed
  10. J Clin Microbiol. 2002 May;40(5):1882-3 - PubMed
  11. J Clin Microbiol. 2007 Jun;45(6):1985-8 - PubMed
  12. J Clin Microbiol. 2003 Sep;41(9):4445-7 - PubMed
  13. Clin Microbiol Infect. 2009 Dec;15(12):1182-5 - PubMed
  14. J Clin Microbiol. 2016 May;54(5):1388-90 - PubMed
  15. J Clin Microbiol. 2013 Feb;51(2):503-7 - PubMed
  16. J Clin Microbiol. 2011 Apr;49(4):1475-82 - PubMed
  17. Infect Dis (Lond). 2016;48(5):386-91 - PubMed

Publication Types